688137 近岸蛋白
已收盘 02-27 15:00:00
资讯
新帖
简况
每周股票复盘：近岸蛋白（688137）回购计划尚未实施
证券之星 · 02-08
每周股票复盘：近岸蛋白（688137）回购计划尚未实施
每周股票复盘：近岸蛋白（688137）预计2025年净亏损6600万至8500万元
证券之星 · 02-01
每周股票复盘：近岸蛋白（688137）预计2025年净亏损6600万至8500万元
1月28日近岸蛋白跌5.90%，浦银安盛增长动力混合A基金重仓该股
中金财经 · 01-28
1月28日近岸蛋白跌5.90%，浦银安盛增长动力混合A基金重仓该股
近岸蛋白跌6.95% 2022年上市募18.6亿元
中金财经 · 01-27
近岸蛋白跌6.95% 2022年上市募18.6亿元
1月26日近岸蛋白涨6.40%，浦银安盛增长动力混合A基金重仓该股
证券之星 · 01-26
1月26日近岸蛋白涨6.40%，浦银安盛增长动力混合A基金重仓该股
每周股票复盘：近岸蛋白（688137）因股价涨幅上榜龙虎榜
证券之星 · 01-18
每周股票复盘：近岸蛋白（688137）因股价涨幅上榜龙虎榜
股市必读：近岸蛋白（688137）登1月13日交易所龙虎榜
证券之星 · 01-14
股市必读：近岸蛋白（688137）登1月13日交易所龙虎榜
千亿出海+天价猴！CRO板块扎堆涨停，这波红利能吃到2026？
中金财经 · 01-13
千亿出海+天价猴！CRO板块扎堆涨停，这波红利能吃到2026？
异动快报：近岸蛋白（688137）1月13日10点2分触及涨停板
证券之星 · 01-13
异动快报：近岸蛋白（688137）1月13日10点2分触及涨停板
每周股票复盘：近岸蛋白（688137）回购进展更新
证券之星 · 01-11
每周股票复盘：近岸蛋白（688137）回购进展更新
近岸蛋白（688137）披露股份回购进展公告，01月05日股价上涨2.62%
证券之星 · 01-05
近岸蛋白（688137）披露股份回购进展公告，01月05日股价上涨2.62%
每周股票复盘：近岸蛋白（688137）新增募资专户余额10,000.03万元
证券之星 · 01-02
每周股票复盘：近岸蛋白（688137）新增募资专户余额10,000.03万元
近岸蛋白（688137）披露关于新增募集资金专户、保荐机构名称变更暨重新签订三方监管协议的公告，12月30日股价下跌1.89%
证券之星 · 2025-12-30
近岸蛋白（688137）披露关于新增募集资金专户、保荐机构名称变更暨重新签订三方监管协议的公告，12月30日股价下跌1.89%
近岸蛋白（688137）披露拟取消监事会并修订公司章程，12月05日股价上涨1.13%
证券之星 · 2025-12-05
近岸蛋白（688137）披露拟取消监事会并修订公司章程，12月05日股价上涨1.13%
近岸蛋白跌3.52% 2022年上市募18.6亿
中金财经 · 2025-12-02
近岸蛋白跌3.52% 2022年上市募18.6亿
近岸蛋白（688137）披露持股5%以下股东减持股份计划公告，11月27日股价上涨0.44%
证券之星 · 2025-11-27
近岸蛋白（688137）披露持股5%以下股东减持股份计划公告，11月27日股价上涨0.44%
近岸蛋白(688137.SH)股东拟合计减持不超0.2%股份
智通财经 · 2025-11-27
近岸蛋白(688137.SH)股东拟合计减持不超0.2%股份
近岸蛋白（688137）披露拟取消监事会并修订公司章程议案，11月26日股价下跌0.89%
证券之星 · 2025-11-26
近岸蛋白（688137）披露拟取消监事会并修订公司章程议案，11月26日股价下跌0.89%
近岸蛋白（688137）披露关于取消监事会、修订《公司章程》及修订、制定公司部分治理制度的公告，11月24日股价上涨2.63%
证券之星 · 2025-11-24
近岸蛋白（688137）披露关于取消监事会、修订《公司章程》及修订、制定公司部分治理制度的公告，11月24日股价上涨2.63%
每周股票复盘：近岸蛋白（688137）拟取消监事会并修订公司章程
证券之星 · 2025-11-23
每周股票复盘：近岸蛋白（688137）拟取消监事会并修订公司章程
公司概况
公司名称：
苏州近岸蛋白质科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-09-29
主营业务：
苏州近岸蛋白质科技股份有限公司的主营业务是靶点及因子类蛋白、重组抗体、酶及试剂的研发、生产和销售及提供生物药、体外诊断、生命科学基础研究等领域的全流程应用解决方案。公司的主要产品是靶点及因子类蛋白、重组抗体、酶及试剂。
发行价格：
106.19
{"stockData":{"symbol":"688137","market":"SH","secType":"STK","nameCN":"近岸蛋白","latestPrice":44.29,"timestamp":1772175600000,"preClose":43.67,"halted":0,"volume":531457,"delay":0,"changeRate":0.0142,"floatShares":32675400,"shares":70175400,"eps":-0.9265,"marketStatus":"已收盘","change":0.62,"latestTime":"02-27 15:00:00","open":43.9,"high":44.41,"low":43.57,"amount":23328800,"amplitude":0.0192,"askPrice":44.3,"askSize":8,"bidPrice":44.29,"bidSize":9,"shortable":0,"etf":0,"ttmEps":-0.9265,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":5,"adr":0,"adjPreClose":43.67,"symbolType":"stock_kcb","openAndCloseTimeList":[[1772155800000,1772163000000],[1772168400000,1772175600000]],"highLimit":48.04,"lowLimit":39.3,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":70175439,"isCdr":false,"pbRate":1.49,"roa":"--","roe":"--","epsLYR":-0.78,"committee":-0.620513,"marketValue":3108000000,"turnoverRate":0.0163,"status":0,"afterMarket":{"amount":0,"volume":0,"close":44.29,"buyVolume":0,"sellVolume":0,"time":1772177637558,"indexStatus":"已收盘 02-27 15:30:00","preClose":43.67},"floatMarketCap":1447000000},"requestUrl":"/m/hq/s/688137/wiki","defaultTab":"wiki","newsList":[{"id":"2609070525","title":"每周股票复盘：近岸蛋白（688137）回购计划尚未实施","url":"https://stock-news.laohu8.com/highlight/detail?id=2609070525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609070525?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:34","pubTimestamp":1770489251,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，近岸蛋白报收于43.98元，较上周的44.35元下跌0.83%。本周，近岸蛋白2月6日盘中最高价报44.68元。2025年10月13日，公司决定将回购实施期限延长6个月至2026年4月13日。截至2026年1月31日，公司尚未实施回购，后续将根据市场情况择机推进回购计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2608229077","title":"每周股票复盘：近岸蛋白（688137）预计2025年净亏损6600万至8500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608229077","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608229077?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:22","pubTimestamp":1769887333,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，近岸蛋白报收于44.35元，较上周的50.0元下跌11.3%。业绩披露要点：2025年扣非后净利润预计亏损6500万元至8400万元，主因费用上升及补助减少。近岸蛋白发布业绩预告，预计2025年全年归属净利润亏损6600万元至8500万元。公司公告汇总苏州近岸蛋白质科技股份有限公司预计2025年年度归属于母公司所有者的净利润为-8,500.00万元到-6,600.00万元，扣除非经常性损益后的净利润为-8,400.00万元至-6,500.00万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2606796705","title":"1月28日近岸蛋白跌5.90%，浦银安盛增长动力混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606796705","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606796705?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:49","pubTimestamp":1769590155,"startTime":"0","endTime":"0","summary":"证券之星消息，1月28日近岸蛋白跌5.90%，收盘报46.58元，换手率8.82%，成交量2.88万手，成交额1.36亿元。重仓近岸蛋白的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为浦银安盛基金的浦银安盛增长动力混合A。浦银安盛增长动力混合A目前规模为5.73亿元，最新净值0.9999，较上一交易日下跌0.19%，近一年上涨19.42%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/28/20260128567778.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/28/20260128567778.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260128/31979485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2606210204","title":"近岸蛋白跌6.95% 2022年上市募18.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606210204","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606210204?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:57","pubTimestamp":1769504268,"startTime":"0","endTime":"0","summary":"中国经济网北京1月27日讯 近岸蛋白 今日股价下跌，截至收盘，该股报49.50元，跌幅6.95%。 近岸蛋白于2022年9月29日在上交所科创板上市，发行价格为106.19元/股，发行股票数量为1,754.3860万股，保荐人为民生证券股份有限公司，保荐代表人为王璐、黄立超。 近岸蛋白首次公开发行股票募集资金总额为186,298.25万元，扣除发行费用后募集资金净额为174,219.58万元。 近岸蛋白首次公开发行股票的发行费用总额为12,078.67万元，其中，承销保荐费用9,842.17万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260127/31975965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2606297333","title":"1月26日近岸蛋白涨6.40%，浦银安盛增长动力混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606297333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606297333?lang=zh_cn&edition=full","pubTime":"2026-01-26 15:39","pubTimestamp":1769413176,"startTime":"0","endTime":"0","summary":"证券之星消息，1月26日近岸蛋白涨6.40%创60日新高，收盘报53.2元，换手率13.6%，成交量4.44万手，成交额2.33亿元。重仓近岸蛋白的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为浦银安盛基金的浦银安盛增长动力混合A。浦银安盛增长动力混合A目前规模为5.73亿元，最新净值1.007，较上一交易日上涨0.52%，近一年上涨18.75%。该公募基金现任基金经理为宋施怡。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600014876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2604265925","title":"每周股票复盘：近岸蛋白（688137）因股价涨幅上榜龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2604265925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604265925?lang=zh_cn&edition=full","pubTime":"2026-01-18 04:27","pubTimestamp":1768681627,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，近岸蛋白报收于47.2元，较上周的42.92元上涨9.97%。本周，近岸蛋白1月14日盘中最高价报51.76元，股价触及近一年最高点。1月12日盘中最低价报42.0元。近岸蛋白当前最新总市值33.12亿元，在生物制品板块市值排名47/51，在两市A股市值排名4448/5183。本周关注点交易信息汇总：近岸蛋白因日收盘价格涨幅达15%登上龙虎榜。此次是近5个交易日内第1次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2603494631","title":"股市必读：近岸蛋白（688137）登1月13日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2603494631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603494631?lang=zh_cn&edition=full","pubTime":"2026-01-14 01:39","pubTimestamp":1768325948,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘，近岸蛋白报收于49.6元，上涨15.43%，换手率17.78%，成交量5.81万手，成交额2.91亿元。当日关注点来自交易信息汇总：1月13日主力资金净流入3431.46万元，占总成交额11.81%。来自龙虎榜上榜：近岸蛋白因日收盘价格涨幅达到15%登上龙虎榜，为近5个交易日内首次上榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400000895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2603750260","title":"千亿出海+天价猴！CRO板块扎堆涨停，这波红利能吃到2026？","url":"https://stock-news.laohu8.com/highlight/detail?id=2603750260","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603750260?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:30","pubTimestamp":1768296601,"startTime":"0","endTime":"0","summary":"据悉，2025年国内创新药BD出海金额突破1000亿美元，2026年预期加速，CRO企业作为研发外包核心服务商直接受益于订单放量。另外，2025年12月，广东、广西等地猴场实验猴已订至2026年上半年，供不应求局面持续，推动CRO企业战略资源溢价。一猴难求除了创新药出海带来的订单红利，实验猴资源的稀缺性进一步推升了CRO企业的战略价值。机构看好企业发展前景机构普遍看好CRO板块2026年的发展前景。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/13/20260113553813.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/13/20260113553813.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260113/31938136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300244","06978","BK1161","300404","BK0186","BK0216","301257","BK0028","301333","BK0197","688137","BK0146","BK1574","BK0042","301060","301230","BK0114","BK0070","BK0236"],"gpt_icon":0},{"id":"2603573063","title":"异动快报：近岸蛋白（688137）1月13日10点2分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2603573063","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603573063?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:05","pubTimestamp":1768269925,"startTime":"0","endTime":"0","summary":"证券之星1月13日盘中消息，10点2分近岸蛋白触及涨停板。其所属行业生物制品目前上涨。领涨股为荣昌生物。该股为CAR-T疗法，干细胞，合成生物概念热股，当日CAR-T疗法概念上涨3.22%，干细胞概念上涨2.63%，合成生物概念上涨1.94%。1月12日的资金流向数据方面，主力资金净流出300.41万元，占总成交额9.42%，游资资金净流出34.05万元，占总成交额1.07%，散户资金净流入334.46万元，占总成交额10.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300010449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2602539891","title":"每周股票复盘：近岸蛋白（688137）回购进展更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2602539891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602539891?lang=zh_cn&edition=full","pubTime":"2026-01-11 04:30","pubTimestamp":1768077024,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，近岸蛋白报收于42.92元，较上周的40.05元上涨7.17%。本周，近岸蛋白1月9日盘中最高价报43.27元。2025年10月13日，公司决定将回购期限延长至2026年4月13日。截至2025年12月31日，公司尚未实施回购，后续将根据市场情况择机推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2601000050","title":"近岸蛋白（688137）披露股份回购进展公告，01月05日股价上涨2.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601000050","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601000050?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:35","pubTimestamp":1767609355,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，近岸蛋白报收于41.1元，较前一交易日上涨2.62%，最新总市值为28.84亿元。该股当日开盘40.06元，最高41.45元，最低40.05元，成交额达3264.04万元，换手率为2.44%。2025年10月13日，公司决定将回购期限延长至2026年4月13日。截至2025年12月31日，公司尚未实施回购，后续将根据市场情况择机推进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500029322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2600303918","title":"每周股票复盘：近岸蛋白（688137）新增募资专户余额10,000.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600303918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600303918?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:09","pubTimestamp":1767298151,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，近岸蛋白报收于40.74元，较上周的41.09元下跌0.85%。本周，近岸蛋白12月23日盘中最高价报42.48元。近岸蛋白当前最新总市值28.11亿元，在生物制品板块市值排名47/51，在两市A股市值排名4655/5181。因原保荐机构民生证券股份有限公司并购重组更名为国联民生证券承销保荐有限公司，公司与募集资金专户银行及新保荐机构重新签署了募集资金三方监管协议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2595713319","title":"近岸蛋白（688137）披露关于新增募集资金专户、保荐机构名称变更暨重新签订三方监管协议的公告，12月30日股价下跌1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595713319","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595713319?lang=zh_cn&edition=full","pubTime":"2025-12-30 22:39","pubTimestamp":1767105555,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘，近岸蛋白报收于39.87元，较前一交易日下跌1.89%，最新总市值为27.98亿元。同时，因原保荐机构民生证券股份有限公司并购重组更名为国联民生证券承销保荐有限公司，公司与募集资金专户银行及新保荐机构重新签署了募集资金三方监管协议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000044548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2589300813","title":"近岸蛋白（688137）披露拟取消监事会并修订公司章程，12月05日股价上涨1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589300813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589300813?lang=zh_cn&edition=full","pubTime":"2025-12-05 22:28","pubTimestamp":1764944896,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘，近岸蛋白报收于40.35元，较前一交易日上涨1.13%，最新总市值为28.32亿元。该股当日开盘39.99元，最高40.48元，最低39.12元，成交额达1248.39万元，换手率为0.96%。根据近日发布的《2025年第二次临时股东大会会议资料》，苏州近岸蛋白质科技股份有限公司拟取消监事会，由董事会审计委员会承担监事会职责，并对《公司章程》及相关治理制度进行修订。上述议案已获董事会审议通过，尚需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500040795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2588297035","title":"近岸蛋白跌3.52% 2022年上市募18.6亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2588297035","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588297035?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:57","pubTimestamp":1764665824,"startTime":"0","endTime":"0","summary":"中国经济网北京12月2日讯 近岸蛋白 今日收报40.62元，跌幅3.52%。 近岸蛋白于2022年9月29日在上交所科创板上市，发行价格为106.19元/股，发行股票数量为1,754.3860万股，保荐人为民生证券股份有限公司，保荐代表人为王璐、黄立超。 近岸蛋白首次公开发行股票募集资金总额为186,298.25万元，扣除发行费用后募集资金净额为174,219.58万元。 近岸蛋白首次公开发行股票的发行费用总额为12,078.67万元，其中保荐机构民生证券股份有限公司获得承销保荐费用9,842.17万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20251202/31838640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2586822686","title":"近岸蛋白（688137）披露持股5%以下股东减持股份计划公告，11月27日股价上涨0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586822686","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586822686?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:34","pubTimestamp":1764254064,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，近岸蛋白报收于41.5元，较前一交易日上涨0.44%，最新总市值为29.12亿元。该股当日开盘41.52元，最高41.81元，最低41.08元，成交额达1649.51万元，换手率为1.22%。减持价格将按市场价格确定，且已履行前期承诺的信息披露义务。公告指出，本次减持不会对公司治理结构和持续经营产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2586246128","title":"近岸蛋白(688137.SH)股东拟合计减持不超0.2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2586246128","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586246128?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:46","pubTimestamp":1764236819,"startTime":"0","endTime":"0","summary":"智通财经APP讯，近岸蛋白(688137.SH)发布公告，南京金溧、苏州金灵和上海普近因自身经营发展和资金需求计划拟通过集中竞价、大宗交易等方式减持所持有的公司部分股份，股东的减持价格按照市场价格确定，减持期间为自公告披露之日起3个交易日后的三个月内。本次拟合计减持不超0.2%公司股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2586585482","title":"近岸蛋白（688137）披露拟取消监事会并修订公司章程议案，11月26日股价下跌0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586585482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586585482?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:51","pubTimestamp":1764150705,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘，近岸蛋白报收于41.32元，较前一交易日下跌0.89%，最新总市值为29亿元。该股当日开盘42.01元，最高42.57元，最低41.15元，成交额达1897.58万元，换手率为1.39%。公司近日发布公告称，将于2025年12月10日召开2025年第二次临时股东大会，会议将审议《关于取消监事会并修订〈公司章程〉的议案》及多项公司治理制度修订议案。现场会议定于苏州市吴江区文苑路88号东恒盛国际大酒店五楼姑苏厅15时30分举行，同时开通网络投票渠道。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0},{"id":"2585463844","title":"近岸蛋白（688137）披露关于取消监事会、修订《公司章程》及修订、制定公司部分治理制度的公告，11月24日股价上涨2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585463844","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585463844?lang=zh_cn&edition=full","pubTime":"2025-11-24 18:00","pubTimestamp":1763978445,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，近岸蛋白报收于41.0元，较前一交易日上涨2.63%，最新总市值为28.77亿元。该股当日开盘39.95元，最高41.11元，最低39.95元，成交额达1616.87万元，换手率为1.22%。近日，苏州近岸蛋白质科技股份有限公司发布公告称，公司拟取消监事会，由董事会审计委员会承担监事会职责。此外，公司还拟修订和制定多项治理制度，部分制度修订需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400023593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"gpt_icon":0},{"id":"2585097105","title":"每周股票复盘：近岸蛋白（688137）拟取消监事会并修订公司章程","url":"https://stock-news.laohu8.com/highlight/detail?id=2585097105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585097105?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:17","pubTimestamp":1763842630,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，近岸蛋白报收于39.95元，较上周的45.1元下跌11.42%。本周关注点公司公告汇总：近岸蛋白拟取消监事会，由董事会审计委员会承担其职责。苏州近岸蛋白质科技股份有限公司拟取消监事会，由董事会审计委员会承担监事会职责。苏州近岸蛋白质科技股份有限公司章程于2025年11月修订，明确公司为永久存续的股份有限公司，注册资本为7,017.5439万元，股票简称“近岸蛋白”，代码688137。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772304437451,"stockEarnings":[{"period":"1week","weight":0.0121},{"period":"1month","weight":-0.0492},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.0355},{"period":"1year","weight":0.2943},{"period":"ytd","weight":0.1059}],"compareEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":0.0028},{"period":"3month","weight":0.0705},{"period":"6month","weight":0.079},{"period":"1year","weight":0.2287},{"period":"ytd","weight":0.0489}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"苏州近岸蛋白质科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6056人(较上一季度减少0.53%)","perCapita":"5395股","listingDate":"2022-09-29","address":"江苏省苏州市吴江区吴江经济技术开发区云创路228号3层,4层","registeredCapital":"7017万元","survey":" 苏州近岸蛋白质科技股份有限公司的主营业务是靶点及因子类蛋白、重组抗体、酶及试剂的研发、生产和销售及提供生物药、体外诊断、生命科学基础研究等领域的全流程应用解决方案。公司的主要产品是靶点及因子类蛋白、重组抗体、酶及试剂。","listedPrice":106.19},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"近岸蛋白(688137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供近岸蛋白(688137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"近岸蛋白,688137,近岸蛋白股票,近岸蛋白股票老虎,近岸蛋白股票老虎国际,近岸蛋白行情,近岸蛋白股票行情,近岸蛋白股价,近岸蛋白股市,近岸蛋白股票价格,近岸蛋白股票交易,近岸蛋白股票购买,近岸蛋白股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"近岸蛋白(688137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供近岸蛋白(688137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}